It’s fall 2020 and the world’s waiting for the first results from the vaccine trials.But as the moment of truth nears, the pressure on the vaccine makers intensifies.And while AstraZeneca and Johnson & Johnson get hit with curveballs, Pfizer finds itself caught in the crossfire of the U.S. Presidential election.